Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026512983> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W3026512983 endingPage "242" @default.
- W3026512983 startingPage "229" @default.
- W3026512983 abstract "The treatment of cancer has improved drastically in recent decades. Better understanding of tumour biology has enabled the development of new treatments, called targeted therapy. These drugs target specific signalling pathways that are necessary for the development of cancer. Immunotherapy is even more novel. These new agents can be classified into different groups, mainly according to their mechanism of action: VEGF inhibitors or anti-angiogenic agents, EGFR inhibitors, mTOR inhibitors, CTLA-4 inhibitors, or PD-1/PD-L1 inhibitors, etc. All these new treatments are accompanied by new adverse effects that radiologists need to know. Understanding the molecular mechanisms of targeted therapies and knowing their adverse effects are vital to imaging assessment and ensuring appropriate treatment. El tratamiento del cáncer ha avanzado drásticamente en las últimas décadas. Un mayor conocimiento de la biología tumoral ha propiciado el desarrollo de nuevos fármacos anticancerígenos, llamados “terapias dirigidas”. Estos fármacos tienen como diana vías de señalización específicas necesarias para el desarrollo del cáncer. Más novedosa es aún la inmunoterapia. Estos nuevos agentes se pueden clasificar en diferentes grupos, principalmente según su mecanismo de acción: inhibidores de VEGF o antiangiogénicos, inhibidores de EGFR, inhibidores de mTOR, inhibidores de CTLA-4, inhibidores de PD-1/PD-L1, etc. Todas estas nuevas terapias traen consigo nuevos efectos adversos que el radiólogo debe conocer. Entender el mecanismo molecular de las terapias dirigidas y reconocer sus efectos adversos es esencial para una correcta valoración radiológica y para proporcionar un tratamiento apropiado." @default.
- W3026512983 created "2020-05-29" @default.
- W3026512983 creator A5053966084 @default.
- W3026512983 creator A5085980481 @default.
- W3026512983 creator A5086296620 @default.
- W3026512983 date "2020-05-01" @default.
- W3026512983 modified "2023-10-16" @default.
- W3026512983 title "Adverse events of targeted anticancer therapies: What radiologists need to know" @default.
- W3026512983 cites W1503285048 @default.
- W3026512983 cites W1969062072 @default.
- W3026512983 cites W1975938021 @default.
- W3026512983 cites W1998462298 @default.
- W3026512983 cites W2002870649 @default.
- W3026512983 cites W2004961788 @default.
- W3026512983 cites W2009539306 @default.
- W3026512983 cites W2012174693 @default.
- W3026512983 cites W2015015957 @default.
- W3026512983 cites W2034287995 @default.
- W3026512983 cites W2062840352 @default.
- W3026512983 cites W2076633810 @default.
- W3026512983 cites W2087898932 @default.
- W3026512983 cites W2108923852 @default.
- W3026512983 cites W2118776368 @default.
- W3026512983 cites W2126621994 @default.
- W3026512983 cites W2129788326 @default.
- W3026512983 cites W2131754429 @default.
- W3026512983 cites W2134449164 @default.
- W3026512983 cites W2136474966 @default.
- W3026512983 cites W2150108534 @default.
- W3026512983 cites W2163895976 @default.
- W3026512983 cites W2168752603 @default.
- W3026512983 cites W2189088783 @default.
- W3026512983 cites W2259730793 @default.
- W3026512983 cites W2302088846 @default.
- W3026512983 cites W2508623887 @default.
- W3026512983 cites W2550419061 @default.
- W3026512983 cites W2581748352 @default.
- W3026512983 cites W2588457571 @default.
- W3026512983 cites W2741283961 @default.
- W3026512983 cites W2743419024 @default.
- W3026512983 cites W2751965733 @default.
- W3026512983 cites W2754721894 @default.
- W3026512983 cites W2799401120 @default.
- W3026512983 cites W2898845456 @default.
- W3026512983 cites W2922884407 @default.
- W3026512983 cites W339004536 @default.
- W3026512983 doi "https://doi.org/10.1016/j.rxeng.2020.03.010" @default.
- W3026512983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32057481" @default.
- W3026512983 hasPublicationYear "2020" @default.
- W3026512983 type Work @default.
- W3026512983 sameAs 3026512983 @default.
- W3026512983 citedByCount "0" @default.
- W3026512983 crossrefType "journal-article" @default.
- W3026512983 hasAuthorship W3026512983A5053966084 @default.
- W3026512983 hasAuthorship W3026512983A5085980481 @default.
- W3026512983 hasAuthorship W3026512983A5086296620 @default.
- W3026512983 hasConcept C121608353 @default.
- W3026512983 hasConcept C126322002 @default.
- W3026512983 hasConcept C197934379 @default.
- W3026512983 hasConcept C2781230642 @default.
- W3026512983 hasConcept C502942594 @default.
- W3026512983 hasConcept C71924100 @default.
- W3026512983 hasConcept C98274493 @default.
- W3026512983 hasConceptScore W3026512983C121608353 @default.
- W3026512983 hasConceptScore W3026512983C126322002 @default.
- W3026512983 hasConceptScore W3026512983C197934379 @default.
- W3026512983 hasConceptScore W3026512983C2781230642 @default.
- W3026512983 hasConceptScore W3026512983C502942594 @default.
- W3026512983 hasConceptScore W3026512983C71924100 @default.
- W3026512983 hasConceptScore W3026512983C98274493 @default.
- W3026512983 hasIssue "3" @default.
- W3026512983 hasLocation W30265129831 @default.
- W3026512983 hasOpenAccess W3026512983 @default.
- W3026512983 hasPrimaryLocation W30265129831 @default.
- W3026512983 hasRelatedWork W1966939585 @default.
- W3026512983 hasRelatedWork W1980199008 @default.
- W3026512983 hasRelatedWork W2109763600 @default.
- W3026512983 hasRelatedWork W2365364931 @default.
- W3026512983 hasRelatedWork W2374781999 @default.
- W3026512983 hasRelatedWork W2418638721 @default.
- W3026512983 hasRelatedWork W2527805684 @default.
- W3026512983 hasRelatedWork W2885964272 @default.
- W3026512983 hasRelatedWork W3111351101 @default.
- W3026512983 hasRelatedWork W4236673861 @default.
- W3026512983 hasVolume "62" @default.
- W3026512983 isParatext "false" @default.
- W3026512983 isRetracted "false" @default.
- W3026512983 magId "3026512983" @default.
- W3026512983 workType "article" @default.